Cargando…

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer

Detalles Bibliográficos
Autores principales:	Henriksen, Peter A., Rankin, Stephen, Lang, Ninian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Primers in Cardio-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308056/ https://www.ncbi.nlm.nih.gov/pubmed/37397086 http://dx.doi.org/10.1016/j.jaccao.2023.05.004

Ejemplares similares

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020)

JACC: CardioOncology: The Meaning of Family
por: Ky, Bonnie, et al.
Publicado: (2021)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021)

JACC: CardioOncology: Reflections on Tremendous Growth With Gratitude
por: Ky, Bonnie
Publicado: (2022)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
por: Minga, Iva, et al.
Publicado: (2023)

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review
por: Tyebally, Sara, et al.
Publicado: (2020)

JACC: CardioOncology 2022 Young Author Award Highlight
por: Ky, Bonnie
Publicado: (2023)

JACC: CardioOncology: Serving and Advancing Our Cardiovascular and Oncology Communities
por: Ky, Bonnie
Publicado: (2020)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

JACC: CardioOncology: Poised to Serve a Maturing, Collaborative Field
por: Ky, Bonnie
Publicado: (2019)

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
por: Li, Yimei, et al.
Publicado: (2022)

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
por: Huang, Yuhsin Vivian, et al.
Publicado: (2022)

CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?
por: Ghosh, Arjun K., et al.
Publicado: (2020)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

Reflections on Our Inaugural Year of JACC: CardioOncology, With Gratitude and Tireless Devotion
por: Ky, Bonnie
Publicado: (2020)

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review
por: Hartnett, Jack, et al.
Publicado: (2021)

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Zullig, Leah L., et al.
Publicado: (2022)

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2022)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology
por: Brown, Sherry-Ann, et al.
Publicado: (2021)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Cardiovascular Disease Related to Immune Therapy: JACC: CardioOncology Special Focus Issue
por: Ky, Bonnie
Publicado: (2022)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations
por: Kambhampati, Swetha, et al.
Publicado: (2023)

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Griffin, Jan M., et al.
Publicado: (2021)

Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Velusamy, Ragani, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

Cardio‐Oncology at the Beginning of a New Decade
por: Grumbach, Isabella M.
Publicado: (2020)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8t7k3uvot5qrm2ef715o5iv1o